Australia, Aug. 31 -- UPG 301 Pty Ltd (ACN: 653392968) has issued a ‘NOTICE OF FIRST MEETING OF CREDITORS OF COMPANY UNDER ADMINISTRATION (MEETING ONLY) - 436E(3)(b)’ on Aug. 27. The following are oth... Read More
Australia, Aug. 31 -- UPG 302 Pty Ltd (ACN: 653392995) has issued a ‘NOTICE OF FIRST MEETING OF CREDITORS OF COMPANY UNDER ADMINISTRATION (MEETING ONLY) - 436E(3)(b)’ on Aug. 27. The following are oth... Read More
Australia, Aug. 31 -- UPG 303 Pty Ltd (ACN: 653393018) has issued a ‘NOTICE OF FIRST MEETING OF CREDITORS OF COMPANY UNDER ADMINISTRATION (MEETING ONLY) - 436E(3)(b)’ on Aug. 27. The following are oth... Read More
Australia, Aug. 31 -- UPG 304 Pty Ltd (ACN: 653393027) has issued a ‘NOTICE OF FIRST MEETING OF CREDITORS OF COMPANY UNDER ADMINISTRATION (MEETING ONLY) - 436E(3)(b)’ on Aug. 27. The following are oth... Read More
Australia, Aug. 31 -- UPG 305 Pty Ltd (ACN: 653393036) has issued a ‘NOTICE OF FIRST MEETING OF CREDITORS OF COMPANY UNDER ADMINISTRATION (MEETING ONLY) - 436E(3)(b)’ on Aug. 27. The following are oth... Read More
TOKYO, Aug. 27 -- Prime Minister and His Cabinet issued the following information: [Provisional translation] On August 27, 2026, Prime Minister Takaichi received a courtesy call from Mr. Hiroo Ota, ... Read More
TOKYO, Aug. 27 -- Prime Minister and His Cabinet issued the following information: [Provisional translation] On August 27, 2026, Prime Minister TAKAICHI attended a meeting of the Ministerial Council... Read More
Tokyo, Aug. 27 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062705) titled 'Individualized Prescription Using Outdoor Fitness Equipment: A Two-Phase In... Read More
Tokyo, Aug. 27 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062701) titled 'The Effect of Improved Temperature Sensation by Menthol Application on Cogn... Read More
Tokyo, Aug. 27 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062700) titled 'Pembrolizumab dose-optimization study with Regression discontinuity design ... Read More